Gastroesophageal Reflux Disease Clinical Trial
Official title:
National Registry for Radiofrequency Ablation in Patients With Barrett's Esophagus
The aim of this study is to establish a nationwide registry to collect data regarding the treatment of Barrett's Esophagus (BE) with radiofrequency ablation. The objective of this registry is to increase the number of data and therefore obtain a raise of quality assurance and improve outcome and patient security. Furthermore to provide participating physicians information and experience for treatment details in the therapy of BE.
For treatment of Barrett's Esophagus (BE), a condition considered as a complication of the
gastroesophageal reflux disease (GERD), radiofrequency ablation (RFA) was introduced as a new
method over 10 years ago. This method is already established in treating low- and high-grade
dysplastic BE, but there is also a recommendation in therapy of non-dysplastic Barrett's
esophagus (NDBE), if patients provide a increased cancer risk profile, such as long history
of GERD (over 10 years), large hiatal hernia (over 3cm), esophagitis, history of BE with
dysplasia or positive family history for gastrointestinal cancer.
In Austria 1 - 3% of the population is estimated to develop BE. The treatment numbers in each
specialized centers therefore is low. To guarantee a better and more potent data analysis,
the establishment of a nationwide registry is crucial. Furthermore this is essential to raise
quality assurance and improve outcome and patients will benefit eventually.
The aim is the participation of about 10 departments, which are all qualified centers and
experts, who offer RFA as a treatment for BE. Thus data can be collected and interpreted more
exact due to the increased number of treated patients. For the purpose of data collection a
structured electronic form will be used. This will further improve treatment documentation
and quality.
Documentation will be performed in participating local centers. High priority is patient
safety and data de-personalization. Data administration and data input should be performed
through qualified medical personal via an online documentation platform. Original patients
charts are archived at each center and data de-personalization is guaranteed via consecutive
numbering when submitted to the study center.
Therefore protection of privacy of participating patients can be assured.
The registry should contain basis data of the patient as well as specific treatment data.
1. Patient data Personal identification number (PIN) Sex Age Place of residence - county
2. GERD history Typical, atypical symptoms Leading symptom Since when symptomatically Since
when proton-pump inhibitor (PPI) treatment, dose Fundoplication y/n, Type, Date
3. Endoscopy Date of diagnosis - Date of endoscopy Endoscopic Classification (Prague)
Histological Classification
4. Treatment Data Catheter type: 360°, 90° Energy: 10/12 J/cm2 Ablation catheter 18, 22,
25, 28, 31mm Ablation from … to … ab ore, length Complications
5. Follow Up Date Endoscopic Classification (Prague) Histological Classification Complete
remission of intestinal metaplasia (CR-IM) Proton-pump inhibitor (PPI), Dose
Inclusion of 500 patients a study period of two years is planned. There will be a possible
extension of the study period, if the registry is successful.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02135107 -
A Double-blind Comparative Study of the Efficacy and Safety of E3810 10mg Once and Twice Daily in Maintenance Therapy for PPI Resistant Gastroesophageal Reflux Disease Patients
|
Phase 3 | |
Completed |
NCT01432392 -
Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease
|
N/A | |
Recruiting |
NCT01249482 -
Symptom Assessment for GERD Patients Receiving H. Pylori Eradication
|
N/A | |
Completed |
NCT01578642 -
Feasibility Study for Evaluating the Effect of Electrical Stimulation on Lower Esophageal Sphincter Pressure and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease
|
Phase 2 | |
Completed |
NCT01200550 -
The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients
|
N/A | |
Unknown status |
NCT01128608 -
The Effect of High PCO2 Solution on Esophageal Acid Sensation
|
N/A | |
Completed |
NCT00998244 -
Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT00978016 -
A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)
|
Phase 2 | |
Completed |
NCT00768196 -
Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD Patients
|
N/A | |
Completed |
NCT00768443 -
Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)
|
N/A | |
Recruiting |
NCT00498082 -
Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux Disease
|
N/A | |
Completed |
NCT00886197 -
Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT00378898 -
Feasibility of Placing Bravo PH Capsule in Proximal Esophagus
|
N/A | |
Completed |
NCT00507377 -
Foreshortened Esophagus and Its Surgical Therapy
|
||
Completed |
NCT00217347 -
Evaluation of Efficiency of Esophageal Capsule Endoscopy in the Screening of Patients With Gastroesophageal Reflux Disease or Dyspepsia as Compared to Upper Endoscopy
|
N/A | |
Completed |
NCT00165022 -
Development of a Novel Disease-Specific Quality of Life Questionnaire for Gastroesophageal Reflux Disease (GERD) Patients in Chinese Population
|
N/A | |
Completed |
NCT00625495 -
Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
|
Phase 4 | |
Completed |
NCT00214552 -
Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
|
Phase 3 | |
Completed |
NCT00618150 -
Patient Education in Gastroesophageal Reflux Disease
|
N/A | |
Completed |
NCT03299985 -
Diaphragmatic Myofascial Release in Gastroesophageal Reflux Disease
|
N/A |